Pfizer’s COVID-19 vaccine and drug sale to top $50 billion in 2022
Pfizer’s COVID-19 vaccine and drug sale to top $50 billion in 2022 Drugmaker, Pfizer has reported having more than double of annual profits due to its sales of vaccines in 2021, forecasting that the company will make more than $50 billion in 2022 for its Covid-19 vaccine and therapeutic. Pfizer, whose vaccine developed with […]
Pfizer’s COVID-19 vaccine and drug sale to top $50 billion in 2022 Read More »